Surani Fernando

Most recent articles by Surani Fernando

Pipeline Report 2022: Patient experience takes center stage
Pipeline Report 2022: Patient experience takes center stage
Surani Fernando
December 7, 2022
11:30 am

The past two years were all about COVID-19 vaccines and therapeutics. Now, imminent approvals in oncology, hematology and autoimmune disorders are set to enhance patient convenience.

Pipeline Report: Several blockbuster drugs are poised to go bigger and broader
Pipeline Report: Several blockbuster drugs are poised to go bigger and broader
Surani Fernando
November 2, 2021
12:00 pm

Therapies in the oncology, neurology and autoimmune disease pipelines could soon pose challenges to existing standards of care.

Pipeline Report 2021: Promising drugs tick along across a range of conditions
Pipeline Report 2021: Promising drugs tick along across a range of conditions
Surani Fernando
December 8, 2020
5:00 am

COVID vaccines and therapeutics receive all the headlines — with good reason — but the pharma pipeline is bursting with A-grade candidates across a range of conditions.

Biogen’s touted Alzheimer’s drug receives thumbs-down from FDA advisory panel
Biogen’s touted Alzheimer’s drug receives thumbs-down from FDA advisory panel
Surani Fernando
November 9, 2020
5:00 am

The agency will issue its final verdict on approval in March.

  • From Our Partners